Molybdenum – a scoping review for Nordic Nutrition Recommendations 2023

Agneta Oskarsson; Maria Kippler

doi:10.29219/fnr.v67.10326

Agneta Oskarsson Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden
Maria Kippler Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden

DOI: https://doi.org/10.29219/fnr.v67.10326

Keywords: molybdenum, molybdate, molybdenum cofactor, nutrition recommendations

Abstract

Molybdenum is an essential element in the form of the molybdenum cofactor (Moco). In humans, Moco is required for four enzymes: xanthine oxidase (XO), aldehyde oxidase, sulfite oxidase (SO), and mitochondrial amidoxime-reducing component (mARC). The enzymes are involved in the oxidation of purines to uric acid, metabolism of aromatic aldehydes and heterocyclic compounds, and in the catabolism of sulfur amino acids. Molybdenum cofactor deficiency is a rare autosomal recessive syndrome due to a defective synthesis of Moco, resulting in a deficiency of all the molybdoenzymes. There are no reports on clinical signs of dietary molybdenum deficiency in otherwise healthy humans. Water-soluble molybdate is efficiently absorbed from the digestive tract. The body retention is regulated by urinary excretion. Plasma molybdenum reflects long-term intake and 24-h urinary excretion is related to recent intake. There are no biochemical markers of molybdenum status. Cereal products are the main contributors to molybdenum dietary intake, estimated to 100–170 μg/day in Nordic studies. Little data are available on molybdenum toxicity in humans. A tolerable upper intake level of molybdenum has been based on reproductive toxicity in rats, but the effects have not been reproduced in more recent studies. The U.S. Institute of Medicine (IOM, present National Academy of Sciences, Engineering, and Medicine; NASEM) established a Recommended Dietary Allowance of 45 μg/day in adult men and women in 2001, based on a small study reporting urinary excretion in balance with intake at 22 μg/day. The European Food Safety Authority (EFSA) considered in 2013 the evidence to be insufficient to derive an Average Requirement and a Population Reference Intake, but proposed an Adequate Intake of 65 μg/day for adults.

Downloads

Download data is not yet available.

References

1.
Novotny JA. Molybdenum nutriture in humans. J Evid Based Complement Altern Med 2011; 16(3): 164–8. doi: 10.1177/2156587211406732

2.
Mendel RR, Kruse T. Cell biology of molybdenum in plants and humans. Biochim Biophys Acta 2012; 1823(9): 1568–79. doi: 10.1016/j.bbamcr.2012.02.007

3.
Mendel RR. The molybdenum cofactor. J Biol Chem 2013; 288(19): 13165–72. doi: 10.1074/jbc.R113.455311

4.
Mayr SJ, Mendel RR, Schwarz G. Molybdenum cofactor biology, evolution and deficiency. Biochim Biophys Acta Mol Cell Res 2021; 1868(1): 118883. doi: 10.1016/j.bbamcr.2020.118883

5.
Havemeyer A, Bittner F, Wollers S, Mendel R, Kunze T, Clement B. Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme. J Biol Chem 2006; 281(46): 34796–802. doi: 10.1074/jbc.M607697200

6.
Blomhoff R, Andersen R, Arnesen EK, Christensen JJ, Eneroth H, Erkkola M, et al. Nordic Nutrition Recommendations 2023. Copenhagen: Nordic Council of Ministers; 2023.

7.
Schwarz G, Belaidi AA. Molybdenum in human health and disease. Met Ions Life Sci 2013; 13: 415–50. doi: 10.1007/978-94-007-7500-8_13

8.
EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on Dietary Reference Values for molybdenum. EFSA Journal 2013; 11(8): 3333, 35 p. doi: 10.2903/j.efsa.2013.3333

9.
Werner E, Giussani A, Heinrichs U, Roth P, Greim H. Biokinetic studies in humans with stable isotopes as tracers. Part 2: uptake of molybdenum from aqueous solutions and labelled foodstuffs. Isotopes Environ Health Stud 1998; 34(3): 297–301. doi: 10.1080/10256019808234063

10.
Novotny JA, Turnlund JR. Molybdenum kinetics in men differ during molybdenum depletion and repletion. J Nutr 2006; 136(4): 953–7. doi: 10.1093/jn/136.4.953

11.
Novotny JA, Turnlund JR. Molybdenum intake influences molybdenum kinetics in men. J Nutr 2007; 137(1): 37–42. doi: 10.1093/jn/137.1.37

12.
Tejada-Jimenez M, Chamizo-Ampudia A, Calatrava V, Galvan A, Fernandez E, Llamas A. From the eukaryotic molybdenum cofactor biosynthesis to the moonlighting enzyme mARC. Molecules 2018; 23(12): 1–19. doi: 10.3390/molecules23123287

13.
Turnlund JR, Keyes WR, Peiffer GL, Chiang G. Molybdenum absorption, excretion, and retention studied with stable isotopes in young men during depletion and repletion. Am J Clin Nutr 1995; 61(5): 1102–9. doi: 10.1093/ajcn/61.5.1102

14.
Kumar R, Joshi G, Kler H, Kalra S, Kaur M, Arya R. Toward an understanding of structural insights of xanthine and aldehyde oxidases: an overview of their inhibitors and role in various diseases. Med Res Rev 2018; 38(4): 1073–125. doi: 10.1002/med.21457

15.
Turnlund JR, Keyes WR. Plasma molybdenum reflects dietary molybdenum intake. J Nutr Biochem 2004; 15(2): 90–5. doi: 10.1016/j.jnutbio.2003.10.003

16.
Versieck J, Hoste J, Vanballenberghe L, Barbier F, Cornelis R, Waelput I. Serum molybdenum in diseases of the liver and biliary system. J Lab Clin Med 1981; 97(4): 535–44.

17.
Simic A, Hansen AF, Syversen T, Lierhagen S, Ciesielski TM, Romundstad PR, et al. Trace elements in whole blood in the general population in Trondelag County, Norway: the HUNT3 Survey. Sci Total Environ 2022; 806(Pt 4): 150875. doi: 10.1016/j.scitotenv.2021.150875

18.
Barregard L, Ellingsen DG, Berlinger B, Weinbruch S, Harari F, Sallsten G. Normal variability of 22 elements in 24-hour urine samples – results from a biobank from healthy non-smoking adults. Int J Hyg Environ Health 2021; 233: 113693. doi: 10.1016/j.ijheh.2021.113693

19.
Hays SM, Macey K, Poddalgoda D, Lu M, Nong A, Aylward LL. Biomonitoring equivalents for molybdenum. Regul Toxicol Pharmacol 2016; 77: 223–9. doi: 10.1016/j.yrtph.2016.03.004

20.
IOM. Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001, 797 p.

21.
Darnerud PO, Becker W, Öhrvik V, Kollander B, Sundström B, Strandler HS, et al. Swedish Market Basket Survey 2015 – per capita-based analysis of nutrients and toxic compounds in market baskets and assessment of benefit or risk. Rapport 26. Uppsala: Livsmedelsverket; 2017.

22.
Abramovich M, Miller A, Yang HF, Friel JK. Molybdenum content of Canadian and US infant formulas. Biol Trace Elem Res 2011; 143(2): 844–53. doi: 10.1007/s12011-010-8950-4

23.
Domellof M. Nutritional care of premature infants: microminerals. World Rev Nutr Diet 2014; 110: 121–39. doi: 10.1159/000358462

24.
Chapter 40. Molybdenum. In Nordic Nutrition Recommendations 2012 – integrating nutrition and physical activity. 5th ed. Copenhagen: Nordic Council of Ministers; 2014.

25.
VKM. Assessment of dietary intake of molybdenum in relation to tolerable upper intake. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food and Environment: Oslo: VKM Report; 2018: 05. Available from: https://vkm.no [cited March 14 2018]

26.
Market Basket, 2010 – chemical analysis, exposure estimation and health-related assessment of nutrients and toxic compounds in Swedish food baskets. Report No 7. Uppsala: Livsmedelsverket; 2012.

27.
Abumrad NN, Schneider AJ, Steel D, Rogers LS. Amino-acid intolerance during prolonged total parenteral-nutrition reversed by molybdate therapy. Am J Clin Nutr 1981; 34(11): 2551–9. doi: 10.1093/ajcn/34.11.2551

28.
Schwarz G. Molybdenum cofactor and human disease. Curr Opin Chem Biol 2016; 31: 179–87. doi: 10.1016/j.cbpa.2016.03.016

29.
Veldman A, Schwahn B, Galloway P, van Spronsen F, Weis BK, Nuesslein T, et al. Successful treatment of molybdenum cofactor deficiency type A with cyclic pyranopterin monophosphate (cPMP) in five patients. J Inherit Metab Dis 2010; 33: S31.

30.
Albin M, Oskarsson A. Molybdenum. In: Nordberg G, Costa M, editors. Handbook on the toxicology of metals volume II specific metals. London: Elsevier, Academic Press; 2021, pp. 601–14.

31.
EFSA. Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Safety and efficacy of a molybdenum compound (E7) sodium molybdate dihydrate as feed additive for sheep based on a dossier submitted by Trouw Nutrition International B.V. EFSA J 2019; 17(2): e05606. doi: 10.2903/j.efsa.2019.5606

32.
Lopez-Alonso M, Miranda M. Copper supplementation, a challenge in cattle. Animals 2020; 10(10): 1890. doi: 10.3390/ani10101890

33.
Czlonkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, et al. Wilson disease. Nat Rev Dis Primers 2018; 4(1): 21. doi: 10.1038/s41572-018-0018-3

34.
Fungwe TV, Buddingh F, Demick DS, Lox CD, Yang MT, Yang SP. The role of dietary molybdenum on estrous activity, fertility, reproduction and molybdenum and copper enzyme-activities of female rats. Nutr Res 1990; 10(5): 515–24. doi: 10.1016/S0271-5317(05)80061-2

35.
Scientific Committee for Food, SCF. Opinion of the scientific committee for food on the tolerable upper intake level of molybdenum. 2000. In: Tolerable Upper Intake Levels for Vitamins and Minerals. Scientific Committee on Food. Scientific Panel on Dietetic Product, Nutrition and Allergies. European Food Safety Authority; 2006. ISBN: 92-9199-014-0

36.
Murray FJ, Tyl RW, Sullivan FM, Tiwary AK, Carey S. Developmental toxicity study of sodium molybdate dihydrate administered in the diet to Sprague Dawley rats. Reprod Toxicol 2014; 49: 202–8. doi: 10.1016/j.reprotox.2014.09.001

37.
Murray FJ, Sullivan FM, Hubbard SA, Hoberman AM, Carey S. A two-generation reproductive toxicity study of sodium molybdate dihydrate administered in drinking water or diet to Sprague-Dawley rats. Reprod Toxicol 2019; 84: 75–92. doi: 10.1016/j.reprotox.2018.11.004

38.
Livsmedelsverket. Riskvärdering av vitaminer och mineraler i kosttillskott. Bilaga 1 till konsekvensutredningen Livsmedelsverkets föreskrifter om kosttillskott och införande av nationella regler om maximivärden för vitaminer och mineraler i kosttillskott. Livsmedelsverket. 9 mars 2020. www.livsmedelverket.se.

39.
Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Molybdenum. US Department of Health ans Human Sevices; 2020.

Molybdenum – a scoping review for Nordic Nutrition Recommendations 2023

Abstract

Downloads

References

Most read articles by the same author(s)